PURPOSE To provide recommendations for the management of patients with metastatic
clear cell renal cell carcinoma (ccRCC). METHODS An Expert Panel conducted a systematic …

Simple Summary Kidney cancer occurs more commonly within the general population and
has historically been associated with morbidity and early death. The most common form of …

Until recently, a dichotomy existed in the front-line approach of metastatic clear-cell renal
cell carcinoma (mRCC). Specifically, patients received either targeted therapy or …

Purpose Systemic therapies (ST) improved contemporary survival rates, relative to historical
in clear cell metastatic renal carcinoma (ccmRCC) patients. The magnitude of this …

Approximately a third of patients diagnosed with kidney cancer in the United States present
with advanced disease and those who present with distant metastases historically had …

Simple Summary First-line treatment options for metastatic clear cell renal cell carcinoma
have significantly increased. The current recommended therapeutic strategy is based on a …

Objective To explore the efficacy and safety of pazopanib in a 'real‐world'setting in
unselected patients, as data regarding unselected patients with metastatic clear‐cell renal …

Introduction Because “real-life” patients often do not meet the strict eligibility criteria of
clinical trials, we assessed the trial eligibility of patients with advanced or metastatic renal …

Background This population-wide retrospective, non-interventional registry study assessed
changes in overall survival (OS) and factors influencing OS in Norwegian patients with renal …

Introduction This systematic review evaluated treatment patterns and guidelines in
advanced/metastatic and adjuvant renal cell carcinoma (RCC) in the Asia-Pacific region …